Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Population

Intervention or exposure

Comparison

Outcome

Any field or review title

Field or topic

Source

Review versions

256 questions in 49 reviews · Haematology

current versions

No studies 256 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Question	Effect	Evidence	Status / GRADE
Yoga in addition to standard care vs standard care only Health‐related quality of life · patients with haematological malignancies Yoga in addition to standard care for patients with haematological malignancies (2014) · Cochrane	no estimate extracted	NR	No studies
Yoga in addition to standard care vs standard care only Adverse events · patients with haematological malignancies Yoga in addition to standard care for patients with haematological malignancies (2014) · Cochrane	no estimate extracted	NR	No studies
Anti‐leukaemic therapy with alemtuzumab vs anti‐leukaemic therapy without alemtuzumab (anti‐leukaemic therapy not identical Overall survival not reported · patients with chronic lymphocytic leukaemia Alemtuzumab for patients with chronic lymphocytic leukaemia (2012) · Cochrane	no estimate extracted	NR	No studies
Anti‐leukaemic therapy with alemtuzumab vs anti‐leukaemic therapy without alemtuzumab (anti‐leukaemic therapy not identical Progression free survival not reported · patients with chronic lymphocytic leukaemia Alemtuzumab for patients with chronic lymphocytic leukaemia (2012) · Cochrane	no estimate extracted	NR	No studies
Intervention NR OS not reported · newly diagnosed or relapsed patients with CLL Rituximab, ofatumumab and other monoclonal anti‐CD20 antibodies for chronic lymphocytic leukaemia (2012) · Cochrane	no estimate extracted	NR	No studies
Cytarabine plus high‐dose methotrexate vs high‐dose methotrexate alone Serious adverse events · patients with primary CNS lymphoma Role of chemotherapy additional to high‐dose methotrexate for primary central nervous system lymphoma (PCNSL) (2012) · Cochrane	no estimate extracted	NR	No studies